Viral and Non-Viral Vector Manufacturing Market is Expected to Reach $27.03 billion by 2031
The advent of advanced therapies, including gene therapy and cell therapy, which employ the use of vectors, has created a huge impact in the field of medicine in the past few decades. Therapies that require genetic modification, including the introduction of therapeutic deoxyribonucleic acid (DNA)/gene into a patient's body or cell, demonstrated tremendous potential for treating several fatal...
0 Comments 0 Shares
Sponsored